CHIcago Cardiogenic Shock symposium
May 15, 2027
CHIcago Cardiogenic Shock symposium
May 15, 2027
Join us at chi-shock 2027!
May 15, 2027
Convene Willis Tower
Chicago, Illinois
COURSE DIRECTORS
Nikhil Narang, MD
Assistant Professor of Medicine
Medical Director of Mechanical Circulatory Support at Endeavor Health
University of Chicago Medicine
Chicago, IL
Manreet K. Kanwar, MD, FACC
Professor of Medicine
Director, Section of Heart Failure and Pulmonary Hypertension
Division of Cardiology
Chicago, IL
COURSE OVERVIEW
The 2027 Chicago Cardiogenic Shock Symposium will bring together multidisciplinary experts in cardiology, critical care, interventional cardiology, advanced heart failure, cardiac surgery, mechanical circulatory support, emergency medicine, and allied health to address the rapidly evolving management of cardiogenic shock. The meeting will focus on translating contemporary evidence into practical, team-based approaches across the entire shock continuum—from early recognition and phenotyping through hemodynamic assessment, pharmacologic therapy, temporary mechanical circulatory support (tMCS), escalation and de-escalation strategies, myocardial recovery, durable LVAD or transplantation, and end-of-life decision-making.
The educational program will use state-of-the-art lectures, case-based discussions, multidisciplinary debates, interactive shock-team simulations, hemodynamic case reviews, device-focused sessions, and challenging "what would you do next?" clinical scenarios. Particular emphasis will be placed on areas in which evidence remains incomplete and practice varies substantially among centers, including timing and selection of tMCS, invasive hemodynamic assessment, right ventricular failure, acute myocardial infarction versus heart-failure-related shock, device escalation, and assessment of recovery.
By convening clinicians from Chicago and beyond, the symposium will also provide a forum for examining how regional shock systems of care can improve communication, referral, transfer, and access to advanced therapies.
About Chi-shock
TARGET AUDIENCE
The symposium is intended for healthcare professionals involved in the recognition, stabilization, referral, and definitive management of patients with cardiogenic shock, including:
- Advanced heart failure and transplant cardiologists
- Interventional cardiologists
- General cardiologists
- Cardiac intensivists and critical care physicians
- Cardiothoracic surgeons
- Emergency medicine physicians
- Fellows and trainees in cardiovascular medicine, critical care, and cardiothoracic surgery
- Advanced practice providers
- Critical care, cath-lab, MCS, LVAD, and transplant nurses
- Perfusionists
- Pharmacists
- ECMO/MCS specialists
- Emergency medical services and transfer-center personnel involved in regional shock systems
The program will be relevant both to clinicians practicing at tertiary/quaternary shock centers and to those at community hospitals responsible for the initial recognition, stabilization, and transfer of patients with cardiogenic shock.
SYMPOSIUM OBJECTIVES
Upon completion of this CME activity, participants will be able to:
- Recognize cardiogenic shock earlier and appropriately classify patients according to shock severity, phenotype, etiology, and trajectory
- Differentiate AMI-related, acute-on-chronic heart failure, right ventricular, biventricular, and other important cardiogenic shock phenotypes
- Interpret invasive and noninvasive hemodynamic data and apply these findings to individualized therapeutic decision-making
- Integrate contemporary randomized clinical trial and observational evidence into decisions regarding temporary mechanical circulatory support
- Select an appropriate tMCS strategy based on ventricular phenotype, shock severity, therapeutic goals, and patient-specific risks.Discuss contemporary management of pulmonary hypertension
